The latest announcement is out from Conmed ( (CNMD) ).
CONMED Corporation announced the appointment of Pat Beyer as President and CEO, effective January 1, 2025, succeeding Curt R. Hartman. The company reported a 4.0% increase in sales for Q3 2024, with diluted net earnings per share rising significantly from $0.50 in Q3 2023 to $1.57. Looking ahead, CONMED adjusted its full-year revenue expectations to $1.300 billion to $1.305 billion and raised its EPS forecast, reflecting strong performance despite recent disruptions.
Learn more about CNMD stock on TipRanks’ Stock Analysis page.
